Immunosuppressants - PDFSEARCH.IO - Document Search Engine

Immunosuppressants
Results: 1821

#	Item
441	HIGHLIGHTS OF PRESCRIBING INFORMATION ————— DOSAGE FORMS AND STRENGTHS ————— These highlights do not include all the information needed to use HUMIRA safely and effectively. See full prescribing info Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2009-03-31 14:12:38 Immunology Monoclonal antibodies Autoimmune diseases Arthritis Rheumatology Adalimumab Infliximab Anakinra Rheumatoid arthritis Medicine Health Immunosuppressants
442	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use HUMIRA(j safely and effectively. See full prescribing information for HUMIRA. HUMIRA (adalimnmab) solution for subcu Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2009-03-31 14:50:03 Immunology Monoclonal antibodies Autoimmune diseases Arthritis Rheumatology Adalimumab Infliximab Anakinra Rheumatoid arthritis Medicine Health Immunosuppressants
443	HUMIRA - adalimumab injection, solution Abbott Laboratories[removed]HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use HUMIRA safely and effectively. See full prescri Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2010-02-23 15:26:45 Immunology Arthritis Monoclonal antibodies Rheumatology Autoimmune diseases Adalimumab Infliximab Anakinra Rheumatoid arthritis Medicine Health Immunosuppressants
444	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use HUMIRA(j safely and effectively. See full prescribing information for HUMIRA. HUMIRA (adalimnmab) solution for subcu Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2009-03-31 14:49:58 Immunology Monoclonal antibodies Autoimmune diseases Arthritis Rheumatology Adalimumab Infliximab Anakinra Rheumatoid arthritis Medicine Health Immunosuppressants
445	Microsoft PowerPoint - Siegel [Compatibility Mode] Add to Reading List Source URL: myeloma.org Language: English - Date: 2012-04-18 11:54:45 Orphan drugs Immunosuppressants Amides Bortezomib Pyrazines Multiple myeloma Vorinostat Lenalidomide International Myeloma Working Group Medicine Chemistry Organic chemistry
446	DOCUMENT INFORMATION PAGE Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2010-06-17 08:51:16 Pharmaceutical sciences Monoclonal antibodies Immunosuppressants Adalimumab Biologic Pharmaceutical drug Histoplasmosis Adverse Event Reporting System Center for Drug Evaluation and Research Food and Drug Administration Pharmacology Medicine
447	Microsoft PowerPoint - Best of ASH[removed]Los AngelesMK [Compatibility Mode] Add to Reading List Source URL: myeloma.org Language: English - Date: 2012-04-18 11:55:02 Immunosuppressants Phthalimides Amides Bortezomib Pyrazines Multiple myeloma Lenalidomide Thalidomide Carfilzomib Chemistry Organic chemistry Medicine
448	DN1067V8 CR25[removed]September 27, 2005 Page 1 of[removed] Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2009-03-31 15:19:22 Health Autoimmune diseases Monoclonal antibodies Arthritis Pharmacology Adalimumab Rheumatoid arthritis Psoriasis Placebo Medicine Immunosuppressants Immunology
449	(""~ DEPARTMENT OF IlAL TH & HUAN SERVICES ~~,:::ti\- , Public Health Service Food and Drug Administration Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2009-04-02 11:06:12 Food and Drug Administration Immunosuppressants Structured Product Labeling Clinical research Adalimumab Clinical trial Center for Drug Evaluation and Research Biologic Prescription medication Pharmacology Medicine Pharmaceutical sciences
450	DOCUMENT INFORMATION PAGE Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2012-01-06 15:04:40 Monoclonal antibodies Adalimumab Immunosuppressants Food and Drug Administration Biologic BLA Abbott Laboratories Rems Pharmacology Pharmaceutical sciences Biotechnology

UPDATE